Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has ...
TipRanks on MSN
Humacyte terminates revenue interest agreement
Humacyte ( ($HUMA) ) has shared an update. On December 15, 2025, Humacyte, Inc. and Humacyte Global, Inc. reached an agreement with TPC ...
Results published in Journal of Vascular Surgery Cases, Innovations and Techniques (JVS-CIT) - - After up to 36 months of follow-up, patients ...
Morning Overview on MSN
Scientists grew human tear glands to crack a painful mystery
Tears seem simple, but the tiny glands that produce them are among the least understood organs in the human body. By growing ...
Biotech today is moving at lightning speed, seriously. It feels like every week there’s something new that changes how we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results